BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Personal Genome Diagnostics Inc. (PGDx), a leader ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Toxikon, a contract research ...

The biomarker test measures NfL levels through standard blood collection. Labcorp has launched the Neurofilament Light Chain (NfL) blood test to identify and verify signs of neuronal damage related to ...

These expansions include a new product, along with improvements to existing products. Labcorp’s precision oncology portfolio is about to get bigger. The company announced expansions to its portfolio ...

BURLINGTON, N.C., Oct. 23, 2025 /PRNewswire/ -- Labcorp, a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the only blood ...

Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2025 results on Oct. 28, before the market opens. The renowned laboratory service provider reported adjusted earnings of ...

BURLINGTON, N.C., Aug. 27, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team ...

Labcorp is updating 2025 full year guidance to reflect its third quarter performance and full year outlook. The following guidance assumes foreign exchange rates effective as of September 30, 2025, ...

Labcorp is a science and healthcare company that provides laboratory testing services worldwide. It also functions as a lab facility that conducts research, clinical studies, diagnostic testing, and ...

Bulto, President, U.S. of Novartis, brings global healthcare leadership and growth track record to support Labcorp's (LH) long-term strategy BURLINGTON, N.C., Nov. 24, 2025 /PRNewswire/ -- Labcorp ...